Chuanxin Biomedical (Suzhou) Co., Ltd. announced that it has received CNY 150,000,000 in a round of funding on June 29, 2023. The transaction included participation from new investor Changchun BCHT Biotechnology Co.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
40.45 CNY | -1.75% | +3.53% | -26.20% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-26.20% | 2.32B | |
+7.91% | 72.03B | |
-10.86% | 5.14B | |
+46.43% | 4.6B | |
+5.38% | 3.96B | |
-16.20% | 2.5B | |
+20.93% | 2.43B | |
+19.92% | 2.18B | |
+8.15% | 1.72B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- 688276 Stock
- News Changchun BCHT Biotechnology Co.
- Chuanxin Biomedical Co., Ltd. announced that it has received CNY 150 million in funding from Changchun BCHT Biotechnology Co.